Dissecting the Application Spectrum: A Detailed Look at the Organ-on-a-Chip Market Segment Focused on Disease Modeling vs. Drug Toxicity Screening
  The Organ-on-a-chip (OoC) market is fundamentally segmented by its core applications, with distinct commercial dynamics separating drug toxicity screening from complex disease modeling. The drug toxicity screening application currently accounts for the largest market share and is the primary revenue driver, as pharmaceutical and cosmetic companies are mandated by regulatory bodies to...
0 Comentários 0 Compartilhamentos 0 Anterior